search

Active clinical trials for "Hyperkinesis"

Results 131-140 of 757

A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that presents during childhood, and is characterized by developmentally inappropriate levels of inattention and/or hyperactive-impulsive behavior. It is proposed that classical homeopathic treatment can reduce the symptoms of ADHD without serious side effects. This is an open label pilot feasibility study (36 participants). Participants, age 6-16, will consult with a homeopathic practitioner who will select treatments based on classical homeopathy principles. All participants will be assessed on a 4-weekly basis for a total of 36 weeks. The purpose of the study is to assess feasibility of recruitment and patient retention, to obtain pilot data on which to base a sample size calculation for future study, and to identify major safety concerns. The study will use single homeopathic medicines approved for over-the-counter use in Canada. The primary outcome measure will be the validated Conners 3rd Edition - Parent.

Completed7 enrollment criteria

Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder...

Attention Deficit Hyperactivity Disorder

The objective of this study was to establish that an optimal dose of Quillivant XR oral suspension would result in a significant reduction in signs and symptoms of ADHD compared to placebo treatment in pediatric patients ages 6-12 years with ADHD.

Completed11 enrollment criteria

Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity...

Attention Deficit Hyperactivity Disorder

This study will test the efficacy of a systematic, multi-modal intervention protocol designed to improve sleep functioning and subsequent alleviation of daytime cognitive and behavioral difficulties among children diagnosed with ADHD. It is hypothesized that children receiving behavioral and (if necessary) pharmacologic interventions targeting sleep will display improvement on objective and subjective sleep measures, neuropsychological tests, and teacher-, and parent-ratings of ADHD behaviors.

Completed16 enrollment criteria

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention...

Attention Deficit Disorder With Hyperactivity

The purpose of this study is to determine whether CLONICEL® (clonidine HCl sustained release) is a safe and effective treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Completed20 enrollment criteria

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder...

Attention-Deficit/Hyperactivity Disorder

The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention-Deficit/Hyperactivity Disorder or ADHD.

Completed13 enrollment criteria

A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention...

Attention Deficit Hyperactivity Disorder

The purpose of this study is to determine whether PF-03654746 is effective in the treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD). This will be a randomized, double-blind, crossover study in which adults with ADHD will receive 3 weeks of treatment with PF-03654746, either a low dose (1 mg), or flexible dose (0.50 mg titrated up to 2 mg), and 3 weeks of placebo. A washout period will separate the 2 treatment periods. Participants will be required to washout of prior ADHD medication before entering the study. Participants will be required to come to the site for 10 visits over approximately a 10-week period.

Completed6 enrollment criteria

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride)...

Attention Deficit Disorder With Hyperactivity

Evaluate the efficacy of treatment with ADDERALL XR and STRATTERA compared to placebo on simulated driving safety and performance of young adults with ADHD as measured by Driving Safety Scores derived by the Driving Simulator.

Completed7 enrollment criteria

Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD...

ADHDAttention Deficit Hyperactivity Disorder

The purpose of this study is to evaluate the safety, effectiveness, and tolerability of atomoxetine and OROS methylphenidate, taken together, in the treatment of ADHD in children and adolescents ages 6-17.

Completed20 enrollment criteria

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate...

Attention Deficit Hyperactivity Disorder

Investigation of efficacy and tolerability of extended-release MPD in adults with ADHD, compared with a placebo, and to acquire knowledge through long-term observation of adults

Completed39 enrollment criteria

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder...

Attention-Deficit/Hyperactivity Disorder

The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention Deficit Hyperactivity Disorder (ADHD).

Completed12 enrollment criteria
1...131415...76

Need Help? Contact our team!


We'll reach out to this number within 24 hrs